Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Inventory Average (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Inventory Average for 15 consecutive years, with $87.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory Average rose 38.34% to $87.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $87.0 million, a 38.34% increase, with the full-year FY2024 number at $65.6 million, up 2.06% from a year prior.
  • Inventory Average was $87.0 million for Q3 2025 at Usana Health Sciences, up from $78.4 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $97.9 million in Q2 2022 to a low of $60.8 million in Q4 2023.
  • A 5-year average of $76.2 million and a median of $73.7 million in 2022 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: plummeted 32.83% in 2023, then skyrocketed 38.34% in 2025.
  • Usana Health Sciences' Inventory Average stood at $93.0 million in 2021, then decreased by 27.72% to $67.2 million in 2022, then decreased by 9.55% to $60.8 million in 2023, then rose by 10.03% to $66.9 million in 2024, then surged by 30.16% to $87.0 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Inventory Average are $87.0 million (Q3 2025), $78.4 million (Q2 2025), and $71.6 million (Q1 2025).